Evidence map›Paper›PMID 38436421›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2024

PRMT5 Promotes T follicular helper Cell Differentiation and Germinal Center Responses during Influenza Virus Infection.

Kaitlin A Read, Stephanie A Amici, Sadaf Farsi, Madeline Cutcliffe, Bella Lee, Chan-Wang Jerry Lio, Hsin-Jung Joyce Wu, Mireia Guerau-de-Arellano, Kenneth J Oestreich

Open access · greenAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Kaitlin A ReadDepartment of Microbial Infection and Immunity, The Ohio State University, Columbus, OH.ORCID 0000-0001-5704-5064
Stephanie A AmiciDivision of Medical Laboratory Science, School of Health and Rehabilitation Sciences, The Ohio State University, Columbus, OH.ORCID 0000-0002-3335-760X
Sadaf FarsiDivision of Medical Laboratory Science, School of Health and Rehabilitation Sciences, The Ohio State University, Columbus, OH.ORCID 0009-0007-7034-0747
Madeline CutcliffeDepartment of Internal Medicine, Division of Rheumatology-Immunology, The Ohio State University, Columbus, OH.ORCID 0000-0001-6718-9862
Bella LeeDepartment of Microbial Infection and Immunity, The Ohio State University, Columbus, OH.ORCID 0000-0002-4848-7829
Chan-Wang Jerry LioDepartment of Microbial Infection and Immunity, The Ohio State University, Columbus, OH.ORCID 0000-0003-3876-6741
Hsin-Jung Joyce WuDepartment of Microbial Infection and Immunity, The Ohio State University, Columbus, OH.
Mireia Guerau-de-ArellanoDepartment of Microbial Infection and Immunity, The Ohio State University, Columbus, OH.ORCID 0000-0002-0600-4593
Kenneth J OestreichDepartment of Microbial Infection and Immunity, The Ohio State University, Columbus, OH.ORCID 0000-0002-3004-072X
The Ohio State University · USThe Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute · USOhio Department of Health · USInstitute for Behavioral Medicine · US

Funding

Translational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI Daniel G. Stover · 1985 to 2026
$132.3M
Identifying novel regulatory pathways underlying T helper 1 cell immune responsesR01AI134972 · NIAID · VIRGINIA POLYTECHNIC INST AND ST UNIV · PI OESTREICH, KENNETH JOSEPH · 2018 to 2022
$1.9M
Novel Epigenetic Modifier Inhibitor Drugs for T cell Modulation in Multiple SclerosisR21AI127354 · NIAID · OHIO STATE UNIVERSITY · PI GUERAU-DE-ARELLANO, MIREIA · 2017 to 2018
$404k
Novel knockout models to analyze CD38 functionR03AI151769 · NIAID · OHIO STATE UNIVERSITY · PI GUERAU-DE-ARELLANO, MIREIA · 2020 to 2021
$156k
NCI NIH HHS P30 CA016058NIAID NIH HHS R01 AI134972NIAID NIH HHS R03 AI151769NIAID NIH HHS R21 AI127354
6 · The paper itself

Abstract

Protein arginine methyltransferases (PRMTs) modify diverse protein targets and regulate numerous cellular processes; yet, their contributions to individual effector T cell responses during infections are incompletely understood. In this study, we identify PRMT5 as a critical regulator of CD4+ T follicular helper cell (Tfh) responses during influenza virus infection in mice. Conditional PRMT5 deletion in murine T cells results in an almost complete ablation of both Tfh and T follicular regulatory populations and, consequently, reduced B cell activation and influenza-specific Ab production. Supporting a potential mechanism, we observe elevated surface expression of IL-2Rα on non-T regulatory effector PRMT5-deficient T cells. Notably, IL-2 signaling is known to negatively impact Tfh differentiation. Collectively, our findings identify PRMT5 as a prominent regulator of Tfh programming, with potential causal links to IL-2 signaling.

Indexed as

Influenza, HumanOrthomyxoviridaeOrthomyxoviridae InfectionsAnimalsCell DifferentiationGerminal CenterHumansInterleukin-2MiceT Follicular Helper CellsInterleukin-2

Identifiers

PMID38436421
PMCPMC11018492
OpenAlexW4392369221

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.